Chemoinformaics analysis of Myricetin 3-O-rhamnoside
| Molecular Weight | 464.379 | nRot | 3 |
| Heavy Atom Molecular Weight | 444.219 | nRig | 24 |
| Exact Molecular Weight | 464.095 | nRing | 4 |
| Solubility: LogS | -4.243 | nHRing | 2 |
| Solubility: LogP | 1.137 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 58.0299 |
| nHD | 8 | BPOL | 26.1401 |
| QED | 0.244 |
| Synth | 4.149 |
| Natural Product Likeliness | 2.192 |
| NR-PPAR-gamma | 0.873 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.027 |
| Pgp-sub | 0.978 |
| HIA | 0.582 |
| CACO-2 | -6.36 |
| MDCK | 0.00000763 |
| BBB | 0.008 |
| PPB | 0.896162 |
| VDSS | 0.876 |
| FU | 0.148645 |
| CYP1A2-inh | 0.33 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.222 |
| CYP2c9-sub | 0.261 |
| CYP2d6-inh | 0.086 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.007 |
| CL | 5.033 |
| T12 | 0.894 |
| hERG | 0.036 |
| Ames | 0.738 |
| ROA | 0.059 |
| SkinSen | 0.943 |
| Carcinogencity | 0.022 |
| EI | 0.848 |
| Respiratory | 0.073 |
| NR-Aromatase | 0.835 |
| Antiviral | Yes |
| Prediction | 0.823815 |